Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Skba Capital Management LLC

Skba Capital Management LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAHGet Rating) by 36.8% in the fourth quarter, Holdings Channel reports. The fund owned 259,150 shares of the company’s stock after buying an additional 69,770 shares during the period. Cardinal Health accounts for approximately 2.5% of Skba Capital Management LLC’s investment portfolio, making the stock its 10th largest holding. Skba Capital Management LLC’s holdings in Cardinal Health were worth $13,344,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CAH. Amundi Pioneer Asset Management Inc. raised its holdings in Cardinal Health by 19.8% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 317,924 shares of the company’s stock valued at $15,307,000 after acquiring an additional 52,482 shares during the last quarter. OLD Mission Capital LLC purchased a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $1,407,000. Russell Investments Group Ltd. grew its stake in shares of Cardinal Health by 21.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 272,521 shares of the company’s stock valued at $13,559,000 after buying an additional 47,242 shares during the period. Mackenzie Financial Corp grew its stake in shares of Cardinal Health by 14.6% in the 3rd quarter. Mackenzie Financial Corp now owns 115,210 shares of the company’s stock valued at $5,698,000 after buying an additional 14,678 shares during the period. Finally, Barclays PLC grew its stake in shares of Cardinal Health by 20.0% in the 3rd quarter. Barclays PLC now owns 628,149 shares of the company’s stock valued at $31,069,000 after buying an additional 104,819 shares during the period. Institutional investors own 84.26% of the company’s stock.

Shares of CAH traded down $0.92 during midday trading on Thursday, reaching $54.98. The stock had a trading volume of 2,748,275 shares, compared to its average volume of 3,000,388. Cardinal Health, Inc. has a 1-year low of $45.85 and a 1-year high of $64.53. The company’s fifty day simple moving average is $58.15 and its two-hundred day simple moving average is $53.35. The company has a market cap of $14.98 billion, a price-to-earnings ratio of 8.52, a PEG ratio of 2.73 and a beta of 0.82. The company has a debt-to-equity ratio of 5.33, a current ratio of 1.08 and a quick ratio of 0.61.

Cardinal Health (NYSE:CAHGet Rating) last announced its quarterly earnings data on Thursday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.54 by ($0.09). Cardinal Health had a negative net margin of 0.54% and a positive return on equity of 155.24%. The firm had revenue of $44.84 billion during the quarter, compared to analyst estimates of $43.20 billion. During the same quarter in the previous year, the business posted $1.53 earnings per share. Cardinal Health’s revenue for the quarter was up 14.2% compared to the same quarter last year. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 5.18 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 15th. Stockholders of record on Friday, July 1st will be issued a $0.4957 dividend. This represents a $1.98 dividend on an annualized basis and a dividend yield of 3.61%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.49. The ex-dividend date of this dividend is Thursday, June 30th. Cardinal Health’s dividend payout ratio (DPR) is presently 29.88%.

Several analysts have recently weighed in on CAH shares. TheStreet cut shares of Cardinal Health from a “c+” rating to a “d+” rating in a research note on Thursday, May 5th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, May 6th. Zacks Investment Research raised shares of Cardinal Health from a “sell” rating to a “hold” rating and set a $55.00 price objective for the company in a research report on Monday, March 14th. Robert W. Baird increased their price objective on shares of Cardinal Health from $52.00 to $57.00 in a research report on Friday, February 4th. Finally, Credit Suisse Group lowered their price objective on shares of Cardinal Health from $60.00 to $58.00 and set a “neutral” rating for the company in a research report on Friday, February 4th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Hold” and a consensus target price of $58.10.

Cardinal Health Company Profile (Get Rating)

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHGet Rating).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.